In a matter involving an antitrust counterclaim, a generic pharmaceutical manufacturer alleged that a blockbuster brand manufacturer attempted to monopolize the market and delay entry of the generic product. A CRA expert was retained to analyze market definition, competitive effects, and lost profits damages estimates. The matter settled favorably for our client shortly before trial.
IP Literature Watch: January 2021
In this issue of IP Literature Watch we include a paper that explores how the Computer Fraud and Abuse Act has become a favorite legal tool for dominant firms...